PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
PMV Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.25+0.04 (+3.72%)
Close on Oct 19, 2026
- Market cap
- $67.00M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.15 (−10.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $67.00M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.94
- Dividend yield
- –
- Free cash flow yield
- -106.39%
Fundamentals
- Net income
- -$75.22M
- EPS, diluted
- -$1.42
- Free cash flow
- -$71.28M
- Book value per share
- $1.34
- Diluted shares
- 53M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Operating income
-$79.66M
Net income
-$75.22M
EPS, diluted
-$1.42
Free cash flow
-$71.28M
Reported periodTrailing twelve months